The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Adlyxin Starter Kit Discontinuation: What Providers and Prescribers Need to Know in 2026
Adlyxin (lixisenatide) was discontinued in the US in January 2023. Here's what prescribers need to know about transitioning patients and selecting appropriate GLP-1 alternatives.
Allopurinol Shortage: What Providers and Prescribers Need to Know in 2026
A clinical update for providers on allopurinol availability in 2026 — including patient counseling guidance, formulary considerations, and when to switch therapy.
Cipro XR Shortage: What Providers and Prescribers Need to Know in 2026
Clinical briefing for providers on Cipro XR availability in 2026: brand discontinuation, generic ER status, prescribing alternatives, and patient access strategies.
Etanercept Shortage: What Providers and Prescribers Need to Know in 2026
Etanercept access is increasingly complex for patients in 2026. This provider guide covers the key barriers, prior auth strategies, and how to support continuity of care.
40,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Leqvio Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of Leqvio availability, prior authorization pathways, and practical guidance for providers managing patients on inclisiran in 2026.
Loteprednol Etabonate: What Providers and Prescribers Need to Know in 2026
A clinical overview of Loteprednol Etabonate supply, formulary status, and prescribing considerations for ophthalmologists and optometrists in 2026.
Vagifem Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of Vagifem availability in 2026 for OB/GYN, primary care, and menopause specialists — including therapeutic alternatives and patient management strategies.
Valtrex Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for prescribers on valacyclovir availability in 2026, therapeutic alternatives, and strategies to help patients get timely antiviral treatment.
Wixela Inhub Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused update on Wixela Inhub availability in 2026: current supply status, patient impact, formulary considerations, and tools to help patients access their inhaler.
Zyprexa Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of Zyprexa (olanzapine) availability in 2026 for providers: shortage status, injectable supply issues, formulary implications, and patient management strategies.
Finacea Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on current Finacea (azelaic acid 15%) availability, insurance barriers, and prescribing strategies that help patients get their medication.
Lactulose Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for prescribers on lactulose availability, formulation considerations, therapeutic alternatives, and how to support patients who struggle to fill their prescriptions.